Clinical study for the 'Wen-Yang Tong-Du' medicine pot in the treatment of ankylosing spondylitis

Phase 1

• Conditions: Ankylosing Spondylitis

• Registration Number: ITMCTR1900002422
• Lead Sponsor: Gansu Provincial Hospital of TCM

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1. Meet the diagnostic criteria for ankylosing spondylitis in Western medicine;
2. those who meet the syndrome of kidney deficiency and cold syndrome;
3. aged between 18 and 40 years old, low back pain for at least 3 months;
4. disease activity >=4 weeks;
5. BASDAI score >4 points;
6. arthritis: bilateral II ~ IV or unilateral III ~ IV or MRI suggest ankle joint active (acute) inflammation;
7. Volunteer to participate in the trial and agree to enter the clinical study and sign the informed consent form.

Exclusion Criteria

1. pregnant or lactating women and allergic to this drug;
2. combined with severe primary diseases such as cerebrovascular, cardiovascular, liver, kidney and hematopoietic system, and mental patients;
3. active infection, lower extremity ulcer, tuberculosis, natural joint or artificial joint septic arthritis within 12 months, and persistent or recurrent pulmonary infection or urinary catheter;
4. In the late stage, the spine was severe, the joints were severely deformed, stiff, and lost labor;
5. other seronegative spondyloarthropathy, or patients with other rheumatism;
6. patients with impaired skin integrity, is not suitable for cupping treatment.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
TCM symptoms;Ankle CT;